世界の若年性黄斑変性症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Juvenile Macular Degeneration Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3307 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、若年性黄斑変性症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アバシンカプタドペゴルナトリウム、エコーチオフェートヨウ化物、エミクススタト塩酸塩、FAB-111、その他）、用途別市場規模（クリニック、病院、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・若年性黄斑変性症治療の市場動向 ・企業の競争状況、市場シェア ・若年性黄斑変性症治療の種類別市場規模（アバシンカプタドペゴルナトリウム、エコーチオフェートヨウ化物、エミクススタト塩酸塩、FAB-111、その他） ・若年性黄斑変性症治療の用途別市場規模（クリニック、病院、在宅ケア） ・若年性黄斑変性症治療の北米市場規模2016-2027（アメリカ、カナダ） ・若年性黄斑変性症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・若年性黄斑変性症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・若年性黄斑変性症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・若年性黄斑変性症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Acucela Inc.、Alkeus Pharmaceuticals Inc、Astellas Pharma Inc、Copernicus Therapeutics Inc、Grupo Ferrer Internacional SA、Iris Pharma、Sanofi） ・結論

Market Analysis and Insights: Global Juvenile Macular Degeneration Treatment Market
The global Juvenile Macular Degeneration Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Juvenile Macular Degeneration Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Juvenile Macular Degeneration Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Juvenile Macular Degeneration Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Juvenile Macular Degeneration Treatment market.

Global Juvenile Macular Degeneration Treatment Scope and Market Size
Juvenile Macular Degeneration Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Juvenile Macular Degeneration Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Avacincaptad Pegol Sodium
Echothiophate Iodide
Emixustat Hydrochloride
FAB-111
Others

Segment by Application
Clinic
Hospital
Homecare

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Acucela Inc.
Alkeus Pharmaceuticals Inc
Astellas Pharma Inc
Copernicus Therapeutics Inc
Grupo Ferrer Internacional SA
Iris Pharma
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Avacincaptad Pegol Sodium
1.2.3 Echothiophate Iodide
1.2.4 Emixustat Hydrochloride
1.2.5 FAB-111
1.2.6 Others
1.3 Market by Application
1.3.1 Global Juvenile Macular Degeneration Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Juvenile Macular Degeneration Treatment Market Perspective (2016-2027)
2.2 Juvenile Macular Degeneration Treatment Growth Trends by Regions
2.2.1 Juvenile Macular Degeneration Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Juvenile Macular Degeneration Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Juvenile Macular Degeneration Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Juvenile Macular Degeneration Treatment Industry Dynamic
2.3.1 Juvenile Macular Degeneration Treatment Market Trends
2.3.2 Juvenile Macular Degeneration Treatment Market Drivers
2.3.3 Juvenile Macular Degeneration Treatment Market Challenges
2.3.4 Juvenile Macular Degeneration Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Juvenile Macular Degeneration Treatment Players by Revenue
3.1.1 Global Top Juvenile Macular Degeneration Treatment Players by Revenue (2016-2021)
3.1.2 Global Juvenile Macular Degeneration Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Juvenile Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Juvenile Macular Degeneration Treatment Revenue
3.4 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio
3.4.1 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Juvenile Macular Degeneration Treatment Revenue in 2020
3.5 Juvenile Macular Degeneration Treatment Key Players Head office and Area Served
3.6 Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
3.7 Date of Enter into Juvenile Macular Degeneration Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Juvenile Macular Degeneration Treatment Breakdown Data by Type
4.1 Global Juvenile Macular Degeneration Treatment Historic Market Size by Type (2016-2021)
4.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Type (2022-2027)

5 Juvenile Macular Degeneration Treatment Breakdown Data by Application
5.1 Global Juvenile Macular Degeneration Treatment Historic Market Size by Application (2016-2021)
5.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Juvenile Macular Degeneration Treatment Market Size (2016-2027)
6.2 North America Juvenile Macular Degeneration Treatment Market Size by Type
6.2.1 North America Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021)
6.2.2 North America Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027)
6.2.3 North America Juvenile Macular Degeneration Treatment Market Size by Type (2016-2027)
6.3 North America Juvenile Macular Degeneration Treatment Market Size by Application
6.3.1 North America Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021)
6.3.2 North America Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027)
6.3.3 North America Juvenile Macular Degeneration Treatment Market Size by Application (2016-2027)
6.4 North America Juvenile Macular Degeneration Treatment Market Size by Country
6.4.1 North America Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021)
6.4.2 North America Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Juvenile Macular Degeneration Treatment Market Size (2016-2027)
7.2 Europe Juvenile Macular Degeneration Treatment Market Size by Type
7.2.1 Europe Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021)
7.2.2 Europe Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027)
7.2.3 Europe Juvenile Macular Degeneration Treatment Market Size by Type (2016-2027)
7.3 Europe Juvenile Macular Degeneration Treatment Market Size by Application
7.3.1 Europe Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021)
7.3.2 Europe Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027)
7.3.3 Europe Juvenile Macular Degeneration Treatment Market Size by Application (2016-2027)
7.4 Europe Juvenile Macular Degeneration Treatment Market Size by Country
7.4.1 Europe Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021)
7.4.2 Europe Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size (2016-2027)
8.2 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Type
8.2.1 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Application
8.3.1 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region
8.4.1 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Juvenile Macular Degeneration Treatment Market Size (2016-2027)
9.2 Latin America Juvenile Macular Degeneration Treatment Market Size by Type
9.2.1 Latin America Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Juvenile Macular Degeneration Treatment Market Size by Type (2016-2027)
9.3 Latin America Juvenile Macular Degeneration Treatment Market Size by Application
9.3.1 Latin America Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Juvenile Macular Degeneration Treatment Market Size by Application (2016-2027)
9.4 Latin America Juvenile Macular Degeneration Treatment Market Size by Country
9.4.1 Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size (2016-2027)
10.2 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Type
10.2.1 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Application
10.3.1 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country
10.4.1 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Acucela Inc.
11.1.1 Acucela Inc. Company Details
11.1.2 Acucela Inc. Business Overview
11.1.3 Acucela Inc. Juvenile Macular Degeneration Treatment Introduction
11.1.4 Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021)
11.1.5 Acucela Inc. Recent Development
11.2 Alkeus Pharmaceuticals Inc
11.2.1 Alkeus Pharmaceuticals Inc Company Details
11.2.2 Alkeus Pharmaceuticals Inc Business Overview
11.2.3 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Introduction
11.2.4 Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021)
11.2.5 Alkeus Pharmaceuticals Inc Recent Development
11.3 Astellas Pharma Inc
11.3.1 Astellas Pharma Inc Company Details
11.3.2 Astellas Pharma Inc Business Overview
11.3.3 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Introduction
11.3.4 Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021)
11.3.5 Astellas Pharma Inc Recent Development
11.4 Copernicus Therapeutics Inc
11.4.1 Copernicus Therapeutics Inc Company Details
11.4.2 Copernicus Therapeutics Inc Business Overview
11.4.3 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Introduction
11.4.4 Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021)
11.4.5 Copernicus Therapeutics Inc Recent Development
11.5 Grupo Ferrer Internacional SA
11.5.1 Grupo Ferrer Internacional SA Company Details
11.5.2 Grupo Ferrer Internacional SA Business Overview
11.5.3 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Introduction
11.5.4 Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021)
11.5.5 Grupo Ferrer Internacional SA Recent Development
11.6 Iris Pharma
11.6.1 Iris Pharma Company Details
11.6.2 Iris Pharma Business Overview
11.6.3 Iris Pharma Juvenile Macular Degeneration Treatment Introduction
11.6.4 Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021)
11.6.5 Iris Pharma Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Juvenile Macular Degeneration Treatment Introduction
11.7.4 Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Avacincaptad Pegol Sodium
Table 3. Key Players of Echothiophate Iodide
Table 4. Key Players of Emixustat Hydrochloride
Table 5. Key Players of FAB-111
Table 6. Key Players of Others
Table 7. Global Juvenile Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Juvenile Macular Degeneration Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Juvenile Macular Degeneration Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2016-2021)
Table 11. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2022-2027)
Table 13. Juvenile Macular Degeneration Treatment Market Trends
Table 14. Juvenile Macular Degeneration Treatment Market Drivers
Table 15. Juvenile Macular Degeneration Treatment Market Challenges
Table 16. Juvenile Macular Degeneration Treatment Market Restraints
Table 17. Global Juvenile Macular Degeneration Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Juvenile Macular Degeneration Treatment Market Share by Players (2016-2021)
Table 19. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2020)
Table 20. Ranking of Global Top Juvenile Macular Degeneration Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Juvenile Macular Degeneration Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
Table 24. Date of Enter into Juvenile Macular Degeneration Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Juvenile Macular Degeneration Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Acucela Inc. Company Details
Table 65. Acucela Inc. Business Overview
Table 66. Acucela Inc. Juvenile Macular Degeneration Treatment Product
Table 67. Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 68. Acucela Inc. Recent Development
Table 69. Alkeus Pharmaceuticals Inc Company Details
Table 70. Alkeus Pharmaceuticals Inc Business Overview
Table 71. Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Product
Table 72. Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 73. Alkeus Pharmaceuticals Inc Recent Development
Table 74. Astellas Pharma Inc Company Details
Table 75. Astellas Pharma Inc Business Overview
Table 76. Astellas Pharma Inc Juvenile Macular Degeneration Treatment Product
Table 77. Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 78. Astellas Pharma Inc Recent Development
Table 79. Copernicus Therapeutics Inc Company Details
Table 80. Copernicus Therapeutics Inc Business Overview
Table 81. Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Product
Table 82. Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 83. Copernicus Therapeutics Inc Recent Development
Table 84. Grupo Ferrer Internacional SA Company Details
Table 85. Grupo Ferrer Internacional SA Business Overview
Table 86. Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Product
Table 87. Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 88. Grupo Ferrer Internacional SA Recent Development
Table 89. Iris Pharma Company Details
Table 90. Iris Pharma Business Overview
Table 91. Iris Pharma Juvenile Macular Degeneration Treatment Product
Table 92. Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 93. Iris Pharma Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Juvenile Macular Degeneration Treatment Product
Table 97. Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 98. Sanofi Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Juvenile Macular Degeneration Treatment Market Share by Type: 2020 VS 2027
Figure 2. Avacincaptad Pegol Sodium Features
Figure 3. Echothiophate Iodide Features
Figure 4. Emixustat Hydrochloride Features
Figure 5. FAB-111 Features
Figure 6. Others Features
Figure 7. Global Juvenile Macular Degeneration Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Homecare Case Studies
Figure 11. Juvenile Macular Degeneration Treatment Report Years Considered
Figure 12. Global Juvenile Macular Degeneration Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Juvenile Macular Degeneration Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Juvenile Macular Degeneration Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2022-2027)
Figure 16. Global Juvenile Macular Degeneration Treatment Market Share by Players in 2020
Figure 17. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Juvenile Macular Degeneration Treatment Revenue in 2020
Figure 19. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Juvenile Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 23. North America Juvenile Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 24. North America Juvenile Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 25. United States Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Juvenile Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 29. Europe Juvenile Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 30. Europe Juvenile Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 31. Germany Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Juvenile Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Juvenile Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Juvenile Macular Degeneration Treatment Market Share by Region (2016-2027)
Figure 41. China Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Juvenile Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Juvenile Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Juvenile Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Juvenile Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Juvenile Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Juvenile Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Juvenile Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Acucela Inc. Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2016-2021)
Figure 61. Alkeus Pharmaceuticals Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2016-2021)
Figure 62. Astellas Pharma Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2016-2021)
Figure 63. Copernicus Therapeutics Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2016-2021)
Figure 64. Grupo Ferrer Internacional SA Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2016-2021)
Figure 65. Iris Pharma Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---